This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Laboratoire Francais Du Fractionnement Et Des Biotechnologies. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gif sur Yvette, FR (2013)
- Les Ulis, FR (2016)
Company Filing History:
Years Active: 2013-2016
Title: Innovations by Nassirah Khandoudi
Introduction
Nassirah Khandoudi is an accomplished inventor based in Les Ulis, France. He has made significant contributions to the field of biotechnology, particularly in the stabilization of immunoglobulin G compositions. With a total of 2 patents, Khandoudi's work is pivotal in enhancing the efficacy of immunoglobulin formulations.
Latest Patents
Khandoudi's latest patents focus on methods for stabilizing immunoglobulin G compositions in both liquid and lyophilized forms. The first patent describes a stabilizing formulation that includes a sugar alcohol, glycine, and a non-ionic detergent. This formulation is designed to maintain the stability of immunoglobulin G compositions, ensuring their effectiveness in various applications. The second patent reiterates the same innovative approach, emphasizing the importance of this stabilizing formulation for both liquid and lyophilized immunoglobulin G compositions.
Career Highlights
Khandoudi is currently associated with Laboratoire Francais Du Fractionnement Et Des Biotechnologies, where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in medical and pharmaceutical fields.
Collaborations
Some of Khandoudi's notable coworkers include Annie Bardat and Edith Begin, who contribute to the collaborative environment that fosters innovation within their research institution.
Conclusion
Nassirah Khandoudi's contributions to the field of biotechnology through his patents on immunoglobulin G stabilization highlight his role as a significant inventor. His work not only advances scientific understanding but also has practical implications for the medical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
